A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Memorial Sloan Kettering Cancer Center
Cogent Biosciences, Inc.
Theseus Pharmaceuticals
CStone Pharmaceuticals
Asan Medical Center
Deciphera Pharmaceuticals, LLC
Novartis
Medical University Innsbruck
National Cancer Institute (NCI)
University of Helsinki
Northwestern University
Northwestern University
FeRx